Liyang Shi Selected Research

Polymers

12/2016

Convergent in situ assembly of injectable lipogel for enzymatically controlled and targeted delivery of hydrophilic molecules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liyang Shi Research Topics

Disease

7	Neoplasms (Cancer) 03/2022 - 11/2015
2	Wounds and Injuries (Trauma) 01/2024 - 01/2018
2	Infections 01/2023 - 01/2018
1	Neoplasm Metastasis (Metastasis) 02/2024
1	Stomach Neoplasms (Stomach Cancer) 02/2024
1	Disseminated Intravascular Coagulation 02/2024
1	Diabetes Mellitus 10/2023
1	Overnutrition 10/2023
1	Non-alcoholic Fatty Liver Disease 10/2023
1	Insulin Resistance 10/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2023
1	Chronic Renal Insufficiency 12/2022
1	Melanoma (Melanoma, Malignant) 03/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Inflammation (Inflammations) 01/2018
1	Hyperthermia 11/2015

Drug/Important Bio-Agent (IBA)

6	HydrogelsIBA 01/2024 - 11/2015
4	Biocompatible Materials (Biomaterials)IBA 01/2024 - 09/2016
2	Hyaluronic Acid (Hyaluronan)IBA 01/2018 - 12/2016
1	Dacarbazine (DIC)FDA LinkGeneric 02/2024
1	RNA (Ribonucleic Acid)IBA 02/2024
1	Carbon MonoxideIBA 01/2024
1	Peptides (Polypeptides)IBA 10/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2023
1	LipidsIBA 10/2023
1	TOR Serine-Threonine KinasesIBA 10/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2023
1	IndicanIBA 12/2022
1	Proteins (Proteins, Gene)FDA Link 12/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022
1	Imiquimod (Aldara)FDA LinkGeneric 03/2022
1	InterferonsIBA 03/2022
1	CytokinesIBA 03/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	7-azaindole dimerIBA 01/2022
1	Metal-Organic FrameworksIBA 01/2022
1	compound 30IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Type 4 Fibroblast Growth Factor ReceptorIBA 01/2022
1	SolutionsIBA 01/2018
1	PolymersIBA 12/2016
1	Liposomes (Liposome)IBA 12/2016

Therapy/Procedure

4	Therapeutics 01/2024 - 11/2015
4	Injections 03/2022 - 11/2015
1	Transplantation 01/2023